Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Exchange Rate Effect: 2015-2025

Historic Exchange Rate Effect for Mesa Laboratories (MLAB) over the last 11 years, with Sep 2025 value amounting to -$104,000.

  • Mesa Laboratories' Exchange Rate Effect fell 110.48% to -$104,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 27.24%. This contributed to the annual value of $1.3 million for FY2025, which is 464.07% up from last year.
  • Per Mesa Laboratories' latest filing, its Exchange Rate Effect stood at -$104,000 for Q3 2025, which was down 106.93% from $1.5 million recorded in Q2 2025.
  • In the past 5 years, Mesa Laboratories' Exchange Rate Effect registered a high of $2.6 million during Q2 2021, and its lowest value of -$2.1 million during Q3 2021.
  • In the last 3 years, Mesa Laboratories' Exchange Rate Effect had a median value of -$175,000 in 2024 and averaged $186,636.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first tumbled by 331.28% in 2021, then soared by 957.71% in 2025.
  • Over the past 5 years, Mesa Laboratories' Exchange Rate Effect (Quarterly) stood at -$834,000 in 2021, then skyrocketed by 279.02% to $1.5 million in 2022, then decreased by 29.54% to $1.1 million in 2023, then tumbled by 138.97% to -$410,000 in 2024, then crashed by 110.48% to -$104,000 in 2025.
  • Its Exchange Rate Effect was -$104,000 in Q3 2025, compared to $1.5 million in Q2 2025 and $900,000 in Q1 2025.